Porphyria cutanea tarda in a chronic hemodialysis patient

End-stage renal failure and long-term hemodialysis (HD) treatment promote the development of genetically conditioned porphyria cutanea tarda (PCT). Iron overload is often associated with this disease and is thought to play a role in its pathogenesis. We report a case of HDrelated PCT, which improv...

Full description

Saved in:

Bibliographic Details
Published in:	Saudi journal of kidney diseases and transplantation Vol. 21; no. 5; pp. 919 - 922
Main Author:	Labidi, Jannet
Format:	Journal Article
Language:	English
Published:	Riyadh, Saudi Arabia Saudi Center for Organ Transplantation 01-09-2010 Medknow Publications and Media Pvt. Ltd Wolters Kluwer Medknow Publications
Subjects:	Adult Biomarkers - blood Biopsy Care and treatment Case studies Complications and side effects Deferoxamine Deferoxamine - therapeutic use Development and progression Diseases Dosage and administration Female Ferritins - blood Fluorescent Antibody Technique Hemodialysis Hemoglobins - metabolism Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - therapy Kidneys Patient outcomes Patients Porphyria Porphyria Cutanea Tarda - diagnosis Porphyria Cutanea Tarda - drug therapy Porphyria Cutanea Tarda - etiology Renal Dialysis - adverse effects Severity of Illness Index Siderophores - therapeutic use Skin - drug effects Skin - pathology Time Factors Treatment Outcome الأمراض الأمراض الجلدية الفشل الكلوي الكلى المرضى دراسات الحالة علم المداواة غسيل الكلى
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!